Your browser doesn't support javascript.
loading
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.
Khozin, Sean; Blumenthal, Gideon M; Zhang, Lijun; Tang, Shenghui; Brower, Margaret; Fox, Emily; Helms, Whitney; Leong, Ruby; Song, Pengfei; Pan, Yuzhuo; Liu, Qi; Zhao, Ping; Zhao, Hong; Lu, Donghao; Tang, Zhe; Al Hakim, Ali; Boyd, Karen; Keegan, Patricia; Justice, Robert; Pazdur, Richard.
Afiliação
  • Khozin S; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland. Sean.Khozin@fda.hhs.gov.
  • Blumenthal GM; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
  • Zhang L; Office of Biostatistics, FDA, Silver Spring, Maryland.
  • Tang S; Office of Biostatistics, FDA, Silver Spring, Maryland.
  • Brower M; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
  • Fox E; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
  • Helms W; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
  • Leong R; Office of Translational Sciences, FDA, Silver Spring, Maryland.
  • Song P; Office of Translational Sciences, FDA, Silver Spring, Maryland.
  • Pan Y; Office of Translational Sciences, FDA, Silver Spring, Maryland.
  • Liu Q; Office of Translational Sciences, FDA, Silver Spring, Maryland.
  • Zhao P; Office of Translational Sciences, FDA, Silver Spring, Maryland.
  • Zhao H; Office of Translational Sciences, FDA, Silver Spring, Maryland.
  • Lu D; Office of New Drug Quality Assessment, FDA, Silver Spring, Maryland.
  • Tang Z; Office of New Drug Quality Assessment, FDA, Silver Spring, Maryland.
  • Al Hakim A; Office of New Drug Quality Assessment, FDA, Silver Spring, Maryland.
  • Boyd K; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
  • Keegan P; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
  • Justice R; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
  • Pazdur R; Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland.
Clin Cancer Res ; 21(11): 2436-9, 2015 Jun 01.
Article em En | MEDLINE | ID: mdl-25754348
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonas / Aprovação de Drogas / Receptores Proteína Tirosina Quinases / Carcinoma Pulmonar de Células não Pequenas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonas / Aprovação de Drogas / Receptores Proteína Tirosina Quinases / Carcinoma Pulmonar de Células não Pequenas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article